Industry Research Reports
Home > Reports > Pharma & Healthcare > Budesonide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Budesonide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Industry: Pharma & Healthcare
Published Date: 2026-07-08
Pages: 167 Pages
Report ld: 5495811
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Budesonide Market Size(US$)
CAGR 2026-2032
3.2%
Market Size,2032
USD 11,245
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 9,309 million
Market Forecast in 2032(Value)
US$ 11,245 million
CAGR
3.2%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Budesonide was estimated to be worth US$ 8994 million in 2025 and is projected to reach US$ 11245 million, growing at a CAGR of 3.2% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Budesonide cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
In 2025, global budesonide production reached approximately 600 tons, the average price is 15000 usd/kg. Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
Market Concentration and Major Players:
Internationally, the budesonide market is highly concentrated, primarily in developed countries like Europe and America. Large manufacturers include AstraZeneca and Teva. Domestically, budesonide still has significant room for growth.
Manufacturing Process and Market Trends:
The budesonide manufacturing process is divided into two ends: the active pharmaceutical ingredient (API) and the inhaled formulation. The API is primarily derived from prednisolone through five steps: esterification, defatting, oxidation, alcoholysis, and condensation. The key change in recent years—replacing the highly toxic osmium tetroxide with potassium permanganate—is cost reduction and harm mitigation. The diastereomer ratio is controlled by ketalization conditions. The core of the formulation lies not in synthesis but in micronization and suspension stabilization. The API undergoes air jet milling to control the particle size to approximately 2 micrometers to match lung deposition. The suspension is then homogenized using microfluidics and coated with phospholipids to enhance physical stability. The inhaled powder formulation requires coupling with a lactose carrier and a metering device. The aerosol formulation has completed the global transition from CFCs to HFA propellants.
In the global market, the patent for AstraZeneca's original Pulmicort expired in 2019, and generic inhalers followed suit in China and India. The demand for chronic diseases such as asthma and COPD constitutes the basic market. Colon-targeted sustained-release formulations have expanded their indications to inflammatory bowel disease, becoming a second growth curve. North America and Europe maintain their main markets due to their medical systems and payment systems. In the Asia-Pacific region, the replacement of generic drugs is accelerating due to centralized procurement and local consistency evaluation. The overall barriers are still in the registration of drug-device integrated inhalation devices and the control of micronization processes. The raw material segment has become more bulky.
This report provides a comprehensive view of the global market for Budesonide, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Dosage Form, and by Application.
The Budesonide market size, estimations, and forecasts are presented in terms of sales volume (Tons) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Budesonide.
MARKET SEGMENTATION
By Company
- AstraZeneca (UK)
- Teva (Israel)
- Viatris (USA)
- Cipla (India)
- Cosmo Pharmaceuticals (Ireland)
- Bausch Health (Canada)
- Chiesi Farmaceutici (Italy)
- Orion Corporation (Finland)
- Axplora (France)
- Industriale Chimica (Italy)
- Aarti Pharmalabs (India)
- Sun Pharma (India)
- Vamsi Labs (India)
- Lupin (India)
- Nephron (USA)
- Takeda (Japan)
- Calliditas (Sweden)
- Dr. Falk Pharma (German)
- Padagis (USA)
- Lunan Better Pharma(China)
- Shanghai Sine Promod(China)
- Chia Tai Tianqing Pharmaceutical Group(China)
- Joincare Pharmaceutical Group Industry(China)
- Sichuan Purity Pharmaceutical(China)
- CF PharmTech(China)
- Zhejiang Furuixi Pharmaceutical(China)
- Yuanda Jiuhe (Jiangxi) Pharmaceutical(China)
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Injectable Suspension
- Aerosols
- Inhalation Powder
- Tablet and Capsule
Segment by Application
- Respiratory Disease Treatment
- Nose Disease Treatment
- Inflammatory Bowel Disease Treatment
- Others
Segment by Category
- Single-agent Budesonide
- Combination Budesonide
Segment by Division
- Budesonide API
- Budesonide Finished Dosage Form
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Budesonide manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Dosage Form, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Budesonide sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Budesonide sales and revenue at the country level. It provides segmented data by Dosage Form and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Budesonide Product Introduction
1.2 Global Budesonide Market Size Forecast
1.2.1 Global Budesonide Sales Value (2021–2032)
1.2.2 Global Budesonide Sales Volume (2021–2032)
1.2.3 Global Budesonide Sales Price (2021–2032)
1.3 Budesonide Market Trends & Drivers
1.3.1 Budesonide Industry Trends
1.3.2 Budesonide Market Drivers & Opportunities
1.3.3 Budesonide Market Challenges
1.3.4 Budesonide Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Budesonide Players Revenue Ranking (2025)
2.2 Global Budesonide Revenue by Company (2021–2026)
2.3 Global Budesonide Sales Volume Ranking of Players (2025)
2.4 Global Budesonide Sales Volume by Company (2021–2026)
2.5 Global Budesonide Average Price by Company (2021–2026)
2.6 Key Manufacturers Budesonide Manufacturing Base and Headquarters
2.7 Key Manufacturers Budesonide Product Offerings
2.8 Key Manufacturers Start of Mass Production of Budesonide
2.9 Budesonide Market Competitive Analysis
2.9.1 Budesonide Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Budesonide Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Budesonide revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Budesonide Market Classification
3.1 Introduction by Dosage Form
3.1.1 Injectable Suspension
3.1.2 Aerosols
3.1.3 Inhalation Powder
3.1.4 Tablet and Capsule
3.1.5 Global Budesonide Sales Value by Dosage Form
3.1.5.1 Global Budesonide Sales Value by Dosage Form (2021 vs 2025 vs 2032)
3.1.5.2 Global Budesonide Sales Value, by Dosage Form (2021–2032)
3.1.5.3 Global Budesonide Sales Value, by Dosage Form (%), 2021–2032
3.1.6 Global Budesonide Sales Volume by Dosage Form
3.1.6.1 Global Budesonide Sales Volume by Dosage Form (2021 vs 2025 vs 2032)
3.1.6.2 Global Budesonide Sales Volume, by Dosage Form (2021–2032)
3.1.6.3 Global Budesonide Sales Volume, by Dosage Form (%), 2021–2032
3.1.7 Global Budesonide Average Price by Dosage Form (2021–2032)
3.2 Introduction by Prescription
3.2.1 Single-agent Budesonide
3.2.2 Combination Budesonide
3.2.3 Global Budesonide Sales Value by Prescription
3.2.3.1 Global Budesonide Sales Value by Prescription (2021 vs 2025 vs 2032)
3.2.3.2 Global Budesonide Sales Value, by Prescription (2021–2032)
3.2.3.3 Global Budesonide Sales Value, by Prescription (%), 2021–2032
3.2.4 Global Budesonide Sales Volume by Prescription
3.2.4.1 Global Budesonide Sales Volume by Prescription (2021 vs 2025 vs 2032)
3.2.4.2 Global Budesonide Sales Volume, by Prescription (2021–2032)
3.2.4.3 Global Budesonide Sales Volume, by Prescription (%), 2021–2032
3.2.5 Global Budesonide Average Price by Prescription (2021–2032)
3.3 Introduction by Specification
3.3.1 Budesonide API
3.3.2 Budesonide Finished Dosage Form
3.3.3 Global Budesonide Sales Value by Specification
3.3.3.1 Global Budesonide Sales Value by Specification (2021 vs 2025 vs 2032)
3.3.3.2 Global Budesonide Sales Value, by Specification (2021–2032)
3.3.3.3 Global Budesonide Sales Value, by Specification (%), 2021–2032
3.3.4 Global Budesonide Sales Volume by Specification
3.3.4.1 Global Budesonide Sales Volume by Specification (2021 vs 2025 vs 2032)
3.3.4.2 Global Budesonide Sales Volume, by Specification (2021–2032)
3.3.4.3 Global Budesonide Sales Volume, by Specification (%), 2021–2032
3.3.5 Global Budesonide Average Price by Specification (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Respiratory Disease Treatment
4.1.2 Nose Disease Treatment
4.1.3 Inflammatory Bowel Disease Treatment
4.1.4 Others
4.2 Global Budesonide Sales Value by Application
4.2.1 Global Budesonide Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Budesonide Sales Value, by Application (2021–2032)
4.2.3 Global Budesonide Sales Value, by Application (%), 2021–2032
4.3 Global Budesonide Sales Volume by Application
4.3.1 Global Budesonide Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Budesonide Sales Volume, by Application (2021–2032)
4.3.3 Global Budesonide Sales Volume, by Application (%), 2021–2032
4.4 Global Budesonide Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Budesonide Sales Value by Region
5.1.1 Global Budesonide Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Budesonide Sales Value by Region (2021–2026)
5.1.3 Global Budesonide Sales Value by Region (2027–2032)
5.1.4 Global Budesonide Sales Value by Region (%), 2021–2032
5.2 Global Budesonide Sales Volume by Region
5.2.1 Global Budesonide Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Budesonide Sales Volume by Region (2021–2026)
5.2.3 Global Budesonide Sales Volume by Region (2027–2032)
5.2.4 Global Budesonide Sales Volume by Region (%), 2021–2032
5.3 Global Budesonide Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Budesonide Sales Value, 2021–2032
5.4.2 North America Budesonide Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Budesonide Sales Value, 2021–2032
5.5.2 Europe Budesonide Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Budesonide Sales Value, 2021–2032
5.6.2 Asia Pacific Budesonide Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Budesonide Sales Value, 2021–2032
5.7.2 South America Budesonide Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Budesonide Sales Value, 2021–2032
5.8.2 Middle East & Africa Budesonide Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Budesonide Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Budesonide Sales Value and Sales Volume
6.2.1 Key Countries/Regions Budesonide Sales Value, 2021–2032
6.2.2 Key Countries/Regions Budesonide Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Budesonide Sales Value, 2021–2032
6.3.2 United States Budesonide Sales Value by Dosage Form (%), 2025 vs 2032
6.3.3 United States Budesonide Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Budesonide Sales Value, 2021–2032
6.4.2 Europe Budesonide Sales Value by Dosage Form (%), 2025 vs 2032
6.4.3 Europe Budesonide Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Budesonide Sales Value, 2021–2032
6.5.2 China Budesonide Sales Value by Dosage Form (%), 2025 vs 2032
6.5.3 China Budesonide Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Budesonide Sales Value, 2021–2032
6.6.2 Japan Budesonide Sales Value by Dosage Form (%), 2025 vs 2032
6.6.3 Japan Budesonide Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Budesonide Sales Value, 2021–2032
6.7.2 South Korea Budesonide Sales Value by Dosage Form (%), 2025 vs 2032
6.7.3 South Korea Budesonide Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Budesonide Sales Value, 2021–2032
6.8.2 Southeast Asia Budesonide Sales Value by Dosage Form (%), 2025 vs 2032
6.8.3 Southeast Asia Budesonide Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Budesonide Sales Value, 2021–2032
6.9.2 India Budesonide Sales Value by Dosage Form (%), 2025 vs 2032
6.9.3 India Budesonide Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 AstraZeneca (UK)
7.1.1 AstraZeneca (UK) Company Information
7.1.2 AstraZeneca (UK) Introduction and Business Overview
7.1.3 AstraZeneca (UK) Budesonide Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 AstraZeneca (UK) Budesonide Product Offerings
7.1.5 AstraZeneca (UK) Recent Developments
7.2 Teva (Israel)
7.2.1 Teva (Israel) Company Information
7.2.2 Teva (Israel) Introduction and Business Overview
7.2.3 Teva (Israel) Budesonide Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Teva (Israel) Budesonide Product Offerings
7.2.5 Teva (Israel) Recent Developments
7.3 Viatris (USA)
7.3.1 Viatris (USA) Company Information
7.3.2 Viatris (USA) Introduction and Business Overview
7.3.3 Viatris (USA) Budesonide Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Viatris (USA) Budesonide Product Offerings
7.3.5 Viatris (USA) Recent Developments
7.4 Cipla (India)
7.4.1 Cipla (India) Company Information
7.4.2 Cipla (India) Introduction and Business Overview
7.4.3 Cipla (India) Budesonide Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Cipla (India) Budesonide Product Offerings
7.4.5 Cipla (India) Recent Developments
7.5 Cosmo Pharmaceuticals (Ireland)
7.5.1 Cosmo Pharmaceuticals (Ireland) Company Information
7.5.2 Cosmo Pharmaceuticals (Ireland) Introduction and Business Overview
7.5.3 Cosmo Pharmaceuticals (Ireland) Budesonide Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Cosmo Pharmaceuticals (Ireland) Budesonide Product Offerings
7.5.5 Cosmo Pharmaceuticals (Ireland) Recent Developments
7.6 Bausch Health (Canada)
7.6.1 Bausch Health (Canada) Company Information
7.6.2 Bausch Health (Canada) Introduction and Business Overview
7.6.3 Bausch Health (Canada) Budesonide Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Bausch Health (Canada) Budesonide Product Offerings
7.6.5 Bausch Health (Canada) Recent Developments
7.7 Chiesi Farmaceutici (Italy)
7.7.1 Chiesi Farmaceutici (Italy) Company Information
7.7.2 Chiesi Farmaceutici (Italy) Introduction and Business Overview
7.7.3 Chiesi Farmaceutici (Italy) Budesonide Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Chiesi Farmaceutici (Italy) Budesonide Product Offerings
7.7.5 Chiesi Farmaceutici (Italy) Recent Developments
7.8 Orion Corporation (Finland)
7.8.1 Orion Corporation (Finland) Company Information
7.8.2 Orion Corporation (Finland) Introduction and Business Overview
7.8.3 Orion Corporation (Finland) Budesonide Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Orion Corporation (Finland) Budesonide Product Offerings
7.8.5 Orion Corporation (Finland) Recent Developments
7.9 Axplora (France)
7.9.1 Axplora (France) Company Information
7.9.2 Axplora (France) Introduction and Business Overview
7.9.3 Axplora (France) Budesonide Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Axplora (France) Budesonide Product Offerings
7.9.5 Axplora (France) Recent Developments
7.10 Industriale Chimica (Italy)
7.10.1 Industriale Chimica (Italy) Company Information
7.10.2 Industriale Chimica (Italy) Introduction and Business Overview
7.10.3 Industriale Chimica (Italy) Budesonide Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Industriale Chimica (Italy) Budesonide Product Offerings
7.10.5 Industriale Chimica (Italy) Recent Developments
7.11 Aarti Pharmalabs (India)
7.11.1 Aarti Pharmalabs (India) Company Information
7.11.2 Aarti Pharmalabs (India) Introduction and Business Overview
7.11.3 Aarti Pharmalabs (India) Budesonide Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Aarti Pharmalabs (India) Budesonide Product Offerings
7.11.5 Aarti Pharmalabs (India) Recent Developments
7.12 Sun Pharma (India)
7.12.1 Sun Pharma (India) Company Information
7.12.2 Sun Pharma (India) Introduction and Business Overview
7.12.3 Sun Pharma (India) Budesonide Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 Sun Pharma (India) Budesonide Product Offerings
7.12.5 Sun Pharma (India) Recent Developments
7.13 Vamsi Labs (India)
7.13.1 Vamsi Labs (India) Company Information
7.13.2 Vamsi Labs (India) Introduction and Business Overview
7.13.3 Vamsi Labs (India) Budesonide Sales, Revenue, Price and Gross Margin (2021–2026)
7.13.4 Vamsi Labs (India) Budesonide Product Offerings
7.13.5 Vamsi Labs (India) Recent Developments
7.14 Lupin (India)
7.14.1 Lupin (India) Company Information
7.14.2 Lupin (India) Introduction and Business Overview
7.14.3 Lupin (India) Budesonide Sales, Revenue, Price and Gross Margin (2021–2026)
7.14.4 Lupin (India) Budesonide Product Offerings
7.14.5 Lupin (India) Recent Developments
7.15 Nephron (USA)
7.15.1 Nephron (USA) Company Information
7.15.2 Nephron (USA) Introduction and Business Overview
7.15.3 Nephron (USA) Budesonide Sales, Revenue, Price and Gross Margin (2021–2026)
7.15.4 Nephron (USA) Budesonide Product Offerings
7.15.5 Nephron (USA) Recent Developments
7.16 Takeda (Japan)
7.16.1 Takeda (Japan) Company Information
7.16.2 Takeda (Japan) Introduction and Business Overview
7.16.3 Takeda (Japan) Budesonide Sales, Revenue, Price and Gross Margin (2021–2026)
7.16.4 Takeda (Japan) Budesonide Product Offerings
7.16.5 Takeda (Japan) Recent Developments
7.17 Calliditas (Sweden)
7.17.1 Calliditas (Sweden) Company Information
7.17.2 Calliditas (Sweden) Introduction and Business Overview
7.17.3 Calliditas (Sweden) Budesonide Sales, Revenue, Price and Gross Margin (2021–2026)
7.17.4 Calliditas (Sweden) Budesonide Product Offerings
7.17.5 Calliditas (Sweden) Recent Developments
7.18 Dr. Falk Pharma (German)
7.18.1 Dr. Falk Pharma (German) Company Information
7.18.2 Dr. Falk Pharma (German) Introduction and Business Overview
7.18.3 Dr. Falk Pharma (German) Budesonide Sales, Revenue, Price and Gross Margin (2021–2026)
7.18.4 Dr. Falk Pharma (German) Budesonide Product Offerings
7.18.5 Dr. Falk Pharma (German) Recent Developments
7.19 Padagis (USA)
7.19.1 Padagis (USA) Company Information
7.19.2 Padagis (USA) Introduction and Business Overview
7.19.3 Padagis (USA) Budesonide Sales, Revenue, Price and Gross Margin (2021–2026)
7.19.4 Padagis (USA) Budesonide Product Offerings
7.19.5 Padagis (USA) Recent Developments
7.20 Lunan Better Pharma(China)
7.20.1 Lunan Better Pharma(China) Company Information
7.20.2 Lunan Better Pharma(China) Introduction and Business Overview
7.20.3 Lunan Better Pharma(China) Budesonide Sales, Revenue, Price and Gross Margin (2021–2026)
7.20.4 Lunan Better Pharma(China) Budesonide Product Offerings
7.20.5 Lunan Better Pharma(China) Recent Developments
7.21 Shanghai Sine Promod(China)
7.21.1 Shanghai Sine Promod(China) Company Information
7.21.2 Shanghai Sine Promod(China) Introduction and Business Overview
7.21.3 Shanghai Sine Promod(China) Budesonide Sales, Revenue, Price and Gross Margin (2021–2026)
7.21.4 Shanghai Sine Promod(China) Budesonide Product Offerings
7.21.5 Shanghai Sine Promod(China) Recent Developments
7.22 Chia Tai Tianqing Pharmaceutical Group(China)
7.22.1 Chia Tai Tianqing Pharmaceutical Group(China) Company Information
7.22.2 Chia Tai Tianqing Pharmaceutical Group(China) Introduction and Business Overview
7.22.3 Chia Tai Tianqing Pharmaceutical Group(China) Budesonide Sales, Revenue, Price and Gross Margin (2021–2026)
7.22.4 Chia Tai Tianqing Pharmaceutical Group(China) Budesonide Product Offerings
7.22.5 Chia Tai Tianqing Pharmaceutical Group(China) Recent Developments
7.23 Joincare Pharmaceutical Group Industry(China)
7.23.1 Joincare Pharmaceutical Group Industry(China) Company Information
7.23.2 Joincare Pharmaceutical Group Industry(China) Introduction and Business Overview
7.23.3 Joincare Pharmaceutical Group Industry(China) Budesonide Sales, Revenue, Price and Gross Margin (2021–2026)
7.23.4 Joincare Pharmaceutical Group Industry(China) Budesonide Product Offerings
7.23.5 Joincare Pharmaceutical Group Industry(China) Recent Developments
7.24 Sichuan Purity Pharmaceutical(China)
7.24.1 Sichuan Purity Pharmaceutical(China) Company Information
7.24.2 Sichuan Purity Pharmaceutical(China) Introduction and Business Overview
7.24.3 Sichuan Purity Pharmaceutical(China) Budesonide Sales, Revenue, Price and Gross Margin (2021–2026)
7.24.4 Sichuan Purity Pharmaceutical(China) Budesonide Product Offerings
7.24.5 Sichuan Purity Pharmaceutical(China) Recent Developments
7.25 CF PharmTech(China)
7.25.1 CF PharmTech(China) Company Information
7.25.2 CF PharmTech(China) Introduction and Business Overview
7.25.3 CF PharmTech(China) Budesonide Sales, Revenue, Price and Gross Margin (2021–2026)
7.25.4 CF PharmTech(China) Budesonide Product Offerings
7.25.5 CF PharmTech(China) Recent Developments
7.26 Zhejiang Furuixi Pharmaceutical(China)
7.26.1 Zhejiang Furuixi Pharmaceutical(China) Company Information
7.26.2 Zhejiang Furuixi Pharmaceutical(China) Introduction and Business Overview
7.26.3 Zhejiang Furuixi Pharmaceutical(China) Budesonide Sales, Revenue, Price and Gross Margin (2021–2026)
7.26.4 Zhejiang Furuixi Pharmaceutical(China) Budesonide Product Offerings
7.26.5 Zhejiang Furuixi Pharmaceutical(China) Recent Developments
7.27 Yuanda Jiuhe (Jiangxi) Pharmaceutical(China)
7.27.1 Yuanda Jiuhe (Jiangxi) Pharmaceutical(China) Company Information
7.27.2 Yuanda Jiuhe (Jiangxi) Pharmaceutical(China) Introduction and Business Overview
7.27.3 Yuanda Jiuhe (Jiangxi) Pharmaceutical(China) Budesonide Sales, Revenue, Price and Gross Margin (2021–2026)
7.27.4 Yuanda Jiuhe (Jiangxi) Pharmaceutical(China) Budesonide Product Offerings
7.27.5 Yuanda Jiuhe (Jiangxi) Pharmaceutical(China) Recent Developments
8 Industry Chain Analysis
8.1 Budesonide Industrial Chain
8.2 Budesonide Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Budesonide Sales Model
8.5.2 Sales Channels
8.5.3 Budesonide Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Budesonide Market Trends
Table 2. Budesonide Market Drivers & Opportunities
Table 3. Budesonide Market Challenges
Table 4. Budesonide Market Restraints
Table 5. Global Budesonide Revenue by Company (US$ Million), 2021–2026
Table 6. Global Budesonide Revenue Market Share by Company (2021–2026)
Table 7. Global Budesonide Sales Volume by Company (Tons), 2021–2026
Table 8. Global Budesonide Sales Volume Market Share by Company (2021–2026)
Table 9. Global Market Budesonide Price by Company (US$/kg), 2021–2026
Table 10. Key Manufacturers Budesonide Manufacturing Base and Headquarters
Table 11. Key Manufacturers Budesonide Product Type
Table 12. Key Manufacturers Start of Mass Production of Budesonide
Table 13. Global Budesonide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Budesonide revenue, 2025
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global Budesonide Sales Value by Dosage Form: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global Budesonide Sales Value by Dosage Form (US$ Million), 2021–2026
Table 18. Global Budesonide Sales Value by Dosage Form (US$ Million), 2027–2032
Table 19. Global Budesonide Sales Market Share in Value by Dosage Form (2021–2026)
Table 20. Global Budesonide Sales Market Share in Value by Dosage Form (2027–2032)
Table 21. Global Budesonide Sales Volume by Dosage Form: 2021 vs 2025 vs 2032 (Tons)
Table 22. Global Budesonide Sales Volume by Dosage Form (Tons), 2021–2026
Table 23. Global Budesonide Sales Volume by Dosage Form (Tons), 2027–2032
Table 24. Global Budesonide Sales Market Share in Volume by Dosage Form (2021–2026)
Table 25. Global Budesonide Sales Market Share in Volume by Dosage Form (2027–2032)
Table 26. Global Budesonide Price by Dosage Form (US$/kg), 2021–2026
Table 27. Global Budesonide Price by Dosage Form (US$/kg), 2027–2032
Table 28. Global Budesonide Sales Value by Prescription: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. Global Budesonide Sales Value by Prescription (US$ Million), 2021–2026
Table 30. Global Budesonide Sales Value by Prescription (US$ Million), 2027–2032
Table 31. Global Budesonide Sales Market Share in Value by Prescription (2021–2026)
Table 32. Global Budesonide Sales Market Share in Value by Prescription (2027–2032)
Table 33. Global Budesonide Sales Volume by Prescription: 2021 vs 2025 vs 2032 (Tons)
Table 34. Global Budesonide Sales Volume by Prescription (Tons), 2021–2026
Table 35. Global Budesonide Sales Volume by Prescription (Tons), 2027–2032
Table 36. Global Budesonide Sales Market Share in Volume by Prescription (2021–2026)
Table 37. Global Budesonide Sales Market Share in Volume by Prescription (2027–2032)
Table 38. Global Budesonide Price by Prescription (US$/kg), 2021–2026
Table 39. Global Budesonide Price by Prescription (US$/kg), 2027–2032
Table 40. Global Budesonide Sales Value by Specification: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Global Budesonide Sales Value by Specification (US$ Million), 2021–2026
Table 42. Global Budesonide Sales Value by Specification (US$ Million), 2027–2032
Table 43. Global Budesonide Sales Market Share in Value by Specification (2021–2026)
Table 44. Global Budesonide Sales Market Share in Value by Specification (2027–2032)
Table 45. Global Budesonide Sales Volume by Specification: 2021 vs 2025 vs 2032 (Tons)
Table 46. Global Budesonide Sales Volume by Specification (Tons), 2021–2026
Table 47. Global Budesonide Sales Volume by Specification (Tons), 2027–2032
Table 48. Global Budesonide Sales Market Share in Volume by Specification (2021–2026)
Table 49. Global Budesonide Sales Market Share in Volume by Specification (2027–2032)
Table 50. Global Budesonide Price by Specification (US$/kg), 2021–2026
Table 51. Global Budesonide Price by Specification (US$/kg), 2027–2032
Table 52. Global Budesonide Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 53. Global Budesonide Sales Value by Application (US$ Million), 2021–2026
Table 54. Global Budesonide Sales Value by Application (US$ Million), 2027–2032
Table 55. Global Budesonide Sales Market Share in Value by Application (2021–2026)
Table 56. Global Budesonide Sales Market Share in Value by Application (2027–2032)
Table 57. Global Budesonide Sales Volume by Application: 2021 vs 2025 vs 2032 (Tons)
Table 58. Global Budesonide Sales Volume by Application (Tons), 2021–2026
Table 59. Global Budesonide Sales Volume by Application (Tons), 2027–2032
Table 60. Global Budesonide Sales Market Share in Volume by Application (2021–2026)
Table 61. Global Budesonide Sales Market Share in Volume by Application (2027–2032)
Table 62. Global Budesonide Price by Application (US$/kg), 2021–2026
Table 63. Global Budesonide Price by Application (US$/kg), 2027–2032
Table 64. Global Budesonide Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 65. Global Budesonide Sales Value by Region (US$ Million), 2021–2026
Table 66. Global Budesonide Sales Value by Region (US$ Million), 2027–2032
Table 67. Global Budesonide Sales Value by Region (%), 2021–2026
Table 68. Global Budesonide Sales Value by Region (%), 2027–2032
Table 69. Global Budesonide Sales Volume by Region (Tons): 2021 vs 2025 vs 2032
Table 70. Global Budesonide Sales Volume by Region (Tons), 2021–2026
Table 71. Global Budesonide Sales Volume by Region (Tons), 2027–2032
Table 72. Global Budesonide Sales Volume by Region (%), 2021–2026
Table 73. Global Budesonide Sales Volume by Region (%), 2027–2032
Table 74. Global Budesonide Average Price by Region (US$/kg), 2021–2026
Table 75. Global Budesonide Average Price by Region (US$/kg), 2027–2032
Table 76. Key Countries/Regions Budesonide Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 77. Key Countries/Regions Budesonide Sales Value, (US$ Million), 2021–2026
Table 78. Key Countries/Regions Budesonide Sales Value, (US$ Million), 2027–2032
Table 79. Key Countries/Regions Budesonide Sales Volume, (Tons), 2021–2026
Table 80. Key Countries/Regions Budesonide Sales Volume, (Tons), 2027–2032
Table 81. AstraZeneca (UK) Company Information
Table 82. AstraZeneca (UK) Introduction and Business Overview
Table 83. AstraZeneca (UK) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 84. AstraZeneca (UK) Budesonide Product Offerings
Table 85. AstraZeneca (UK) Recent Developments
Table 86. Teva (Israel) Company Information
Table 87. Teva (Israel) Introduction and Business Overview
Table 88. Teva (Israel) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 89. Teva (Israel) Budesonide Product Offerings
Table 90. Teva (Israel) Recent Developments
Table 91. Viatris (USA) Company Information
Table 92. Viatris (USA) Introduction and Business Overview
Table 93. Viatris (USA) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 94. Viatris (USA) Budesonide Product Offerings
Table 95. Viatris (USA) Recent Developments
Table 96. Cipla (India) Company Information
Table 97. Cipla (India) Introduction and Business Overview
Table 98. Cipla (India) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 99. Cipla (India) Budesonide Product Offerings
Table 100. Cipla (India) Recent Developments
Table 101. Cosmo Pharmaceuticals (Ireland) Company Information
Table 102. Cosmo Pharmaceuticals (Ireland) Introduction and Business Overview
Table 103. Cosmo Pharmaceuticals (Ireland) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 104. Cosmo Pharmaceuticals (Ireland) Budesonide Product Offerings
Table 105. Cosmo Pharmaceuticals (Ireland) Recent Developments
Table 106. Bausch Health (Canada) Company Information
Table 107. Bausch Health (Canada) Introduction and Business Overview
Table 108. Bausch Health (Canada) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 109. Bausch Health (Canada) Budesonide Product Offerings
Table 110. Bausch Health (Canada) Recent Developments
Table 111. Chiesi Farmaceutici (Italy) Company Information
Table 112. Chiesi Farmaceutici (Italy) Introduction and Business Overview
Table 113. Chiesi Farmaceutici (Italy) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 114. Chiesi Farmaceutici (Italy) Budesonide Product Offerings
Table 115. Chiesi Farmaceutici (Italy) Recent Developments
Table 116. Orion Corporation (Finland) Company Information
Table 117. Orion Corporation (Finland) Introduction and Business Overview
Table 118. Orion Corporation (Finland) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 119. Orion Corporation (Finland) Budesonide Product Offerings
Table 120. Orion Corporation (Finland) Recent Developments
Table 121. Axplora (France) Company Information
Table 122. Axplora (France) Introduction and Business Overview
Table 123. Axplora (France) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 124. Axplora (France) Budesonide Product Offerings
Table 125. Axplora (France) Recent Developments
Table 126. Industriale Chimica (Italy) Company Information
Table 127. Industriale Chimica (Italy) Introduction and Business Overview
Table 128. Industriale Chimica (Italy) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 129. Industriale Chimica (Italy) Budesonide Product Offerings
Table 130. Industriale Chimica (Italy) Recent Developments
Table 131. Aarti Pharmalabs (India) Company Information
Table 132. Aarti Pharmalabs (India) Introduction and Business Overview
Table 133. Aarti Pharmalabs (India) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 134. Aarti Pharmalabs (India) Budesonide Product Offerings
Table 135. Aarti Pharmalabs (India) Recent Developments
Table 136. Sun Pharma (India) Company Information
Table 137. Sun Pharma (India) Introduction and Business Overview
Table 138. Sun Pharma (India) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 139. Sun Pharma (India) Budesonide Product Offerings
Table 140. Sun Pharma (India) Recent Developments
Table 141. Vamsi Labs (India) Company Information
Table 142. Vamsi Labs (India) Introduction and Business Overview
Table 143. Vamsi Labs (India) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 144. Vamsi Labs (India) Budesonide Product Offerings
Table 145. Vamsi Labs (India) Recent Developments
Table 146. Lupin (India) Company Information
Table 147. Lupin (India) Introduction and Business Overview
Table 148. Lupin (India) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 149. Lupin (India) Budesonide Product Offerings
Table 150. Lupin (India) Recent Developments
Table 151. Nephron (USA) Company Information
Table 152. Nephron (USA) Introduction and Business Overview
Table 153. Nephron (USA) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 154. Nephron (USA) Budesonide Product Offerings
Table 155. Nephron (USA) Recent Developments
Table 156. Takeda (Japan) Company Information
Table 157. Takeda (Japan) Introduction and Business Overview
Table 158. Takeda (Japan) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 159. Takeda (Japan) Budesonide Product Offerings
Table 160. Takeda (Japan) Recent Developments
Table 161. Calliditas (Sweden) Company Information
Table 162. Calliditas (Sweden) Introduction and Business Overview
Table 163. Calliditas (Sweden) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 164. Calliditas (Sweden) Budesonide Product Offerings
Table 165. Calliditas (Sweden) Recent Developments
Table 166. Dr. Falk Pharma (German) Company Information
Table 167. Dr. Falk Pharma (German) Introduction and Business Overview
Table 168. Dr. Falk Pharma (German) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 169. Dr. Falk Pharma (German) Budesonide Product Offerings
Table 170. Dr. Falk Pharma (German) Recent Developments
Table 171. Padagis (USA) Company Information
Table 172. Padagis (USA) Introduction and Business Overview
Table 173. Padagis (USA) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 174. Padagis (USA) Budesonide Product Offerings
Table 175. Padagis (USA) Recent Developments
Table 176. Lunan Better Pharma(China) Company Information
Table 177. Lunan Better Pharma(China) Introduction and Business Overview
Table 178. Lunan Better Pharma(China) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 179. Lunan Better Pharma(China) Budesonide Product Offerings
Table 180. Lunan Better Pharma(China) Recent Developments
Table 181. Shanghai Sine Promod(China) Company Information
Table 182. Shanghai Sine Promod(China) Introduction and Business Overview
Table 183. Shanghai Sine Promod(China) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 184. Shanghai Sine Promod(China) Budesonide Product Offerings
Table 185. Shanghai Sine Promod(China) Recent Developments
Table 186. Chia Tai Tianqing Pharmaceutical Group(China) Company Information
Table 187. Chia Tai Tianqing Pharmaceutical Group(China) Introduction and Business Overview
Table 188. Chia Tai Tianqing Pharmaceutical Group(China) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 189. Chia Tai Tianqing Pharmaceutical Group(China) Budesonide Product Offerings
Table 190. Chia Tai Tianqing Pharmaceutical Group(China) Recent Developments
Table 191. Joincare Pharmaceutical Group Industry(China) Company Information
Table 192. Joincare Pharmaceutical Group Industry(China) Introduction and Business Overview
Table 193. Joincare Pharmaceutical Group Industry(China) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 194. Joincare Pharmaceutical Group Industry(China) Budesonide Product Offerings
Table 195. Joincare Pharmaceutical Group Industry(China) Recent Developments
Table 196. Sichuan Purity Pharmaceutical(China) Company Information
Table 197. Sichuan Purity Pharmaceutical(China) Introduction and Business Overview
Table 198. Sichuan Purity Pharmaceutical(China) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 199. Sichuan Purity Pharmaceutical(China) Budesonide Product Offerings
Table 200. Sichuan Purity Pharmaceutical(China) Recent Developments
Table 201. CF PharmTech(China) Company Information
Table 202. CF PharmTech(China) Introduction and Business Overview
Table 203. CF PharmTech(China) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 204. CF PharmTech(China) Budesonide Product Offerings
Table 205. CF PharmTech(China) Recent Developments
Table 206. Zhejiang Furuixi Pharmaceutical(China) Company Information
Table 207. Zhejiang Furuixi Pharmaceutical(China) Introduction and Business Overview
Table 208. Zhejiang Furuixi Pharmaceutical(China) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 209. Zhejiang Furuixi Pharmaceutical(China) Budesonide Product Offerings
Table 210. Zhejiang Furuixi Pharmaceutical(China) Recent Developments
Table 211. Yuanda Jiuhe (Jiangxi) Pharmaceutical(China) Company Information
Table 212. Yuanda Jiuhe (Jiangxi) Pharmaceutical(China) Introduction and Business Overview
Table 213. Yuanda Jiuhe (Jiangxi) Pharmaceutical(China) Budesonide Sales (Tons), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2021–2026)
Table 214. Yuanda Jiuhe (Jiangxi) Pharmaceutical(China) Budesonide Product Offerings
Table 215. Yuanda Jiuhe (Jiangxi) Pharmaceutical(China) Recent Developments
Table 216. Key Raw Materials Lists
Table 217. Key Suppliers of Raw Materials Lists
Table 218. Budesonide Downstream Customers
Table 219. Budesonide Distributors List
Table 220. Research Programs/Design for This Report
Table 221. Key Data Information from Secondary Sources
Table 222. Key Data Information from Primary Sources
List of Figures
Figure 1. Budesonide Product Picture
Figure 2. Global Budesonide Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Budesonide Sales Value (US$ Million), 2021–2032
Figure 4. Global Budesonide Sales Volume (Tons), 2021–2032
Figure 5. Global Budesonide Sales Price (US$/kg), 2021–2032
Figure 6. Budesonide Report Years Considered
Figure 7. Global Budesonide Players Revenue Ranking (US$ Million), 2025
Figure 8. Global Budesonide Sales Volume Ranking of Players (Tons), 2025
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Budesonide Revenue in 2025
Figure 10. Budesonide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 11. Injectable Suspension Picture
Figure 12. Aerosols Picture
Figure 13. Inhalation Powder Picture
Figure 14. Tablet and Capsule Picture
Figure 15. Global Budesonide Sales Value by Dosage Form (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Budesonide Sales Value Market Share by Dosage Form, 2025 & 2032
Figure 17. Global Budesonide Sales Volume by Dosage Form (Tons), 2021 vs 2025 vs 2032
Figure 18. Global Budesonide Sales Volume Market Share by Dosage Form, 2025 & 2032
Figure 19. Global Budesonide Price by Dosage Form (US$/kg), 2021–2032
Figure 20. Single-agent Budesonide Picture
Figure 21. Combination Budesonide Picture
Figure 22. Global Budesonide Sales Value by Prescription (US$ Million), 2021 vs 2025 vs 2032
Figure 23. Global Budesonide Sales Value Market Share by Prescription, 2025 & 2032
Figure 24. Global Budesonide Sales Volume by Prescription (Tons), 2021 vs 2025 vs 2032
Figure 25. Global Budesonide Sales Volume Market Share by Prescription, 2025 & 2032
Figure 26. Global Budesonide Price by Prescription (US$/kg), 2021–2032
Figure 27. Budesonide API Picture
Figure 28. Budesonide Finished Dosage Form Picture
Figure 29. Global Budesonide Sales Value by Specification (US$ Million), 2021 vs 2025 vs 2032
Figure 30. Global Budesonide Sales Value Market Share by Specification, 2025 & 2032
Figure 31. Global Budesonide Sales Volume by Specification (Tons), 2021 vs 2025 vs 2032
Figure 32. Global Budesonide Sales Volume Market Share by Specification, 2025 & 2032
Figure 33. Global Budesonide Price by Specification (US$/kg), 2021–2032
Figure 34. Product Picture of Respiratory Disease Treatment
Figure 35. Product Picture of Nose Disease Treatment
Figure 36. Product Picture of Inflammatory Bowel Disease Treatment
Figure 37. Product Picture of Others
Figure 38. Global Budesonide Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 39. Global Budesonide Sales Value Market Share by Application, 2025 & 2032
Figure 40. Global Budesonide Sales Volume by Application (Tons), 2021 vs 2025 vs 2032
Figure 41. Global Budesonide Sales Volume Market Share by Application, 2025 & 2032
Figure 42. Global Budesonide Price by Application (US$/kg), 2021–2032
Figure 43. North America Budesonide Sales Value (US$ Million), 2021–2032
Figure 44. North America Budesonide Sales Value by Country (%), 2025 vs 2032
Figure 45. Europe Budesonide Sales Value (US$ Million), 2021–2032
Figure 46. Europe Budesonide Sales Value by Country (%), 2025 vs 2032
Figure 47. Asia Pacific Budesonide Sales Value (US$ Million), 2021–2032
Figure 48. Asia Pacific Budesonide Sales Value by Region (%), 2025 vs 2032
Figure 49. South America Budesonide Sales Value (US$ Million), 2021–2032
Figure 50. South America Budesonide Sales Value by Country (%), 2025 vs 2032
Figure 51. Middle East & Africa Budesonide Sales Value (US$ Million), 2021–2032
Figure 52. Middle East & Africa Budesonide Sales Value by Country (%), 2025 vs 2032
Figure 53. Key Countries/Regions Budesonide Sales Value (%), 2021–2032
Figure 54. Key Countries/Regions Budesonide Sales Volume (%), 2021–2032
Figure 55. United States Budesonide Sales Value (US$ Million), 2021–2032
Figure 56. United States Budesonide Sales Value by Dosage Form (%), 2025 vs 2032
Figure 57. United States Budesonide Sales Value by Application (%), 2025 vs 2032
Figure 58. Europe Budesonide Sales Value (US$ Million), 2021–2032
Figure 59. Europe Budesonide Sales Value by Dosage Form (%), 2025 vs 2032
Figure 60. Europe Budesonide Sales Value by Application (%), 2025 vs 2032
Figure 61. China Budesonide Sales Value (US$ Million), 2021–2032
Figure 62. China Budesonide Sales Value by Dosage Form (%), 2025 vs 2032
Figure 63. China Budesonide Sales Value by Application (%), 2025 vs 2032
Figure 64. Japan Budesonide Sales Value (US$ Million), 2021–2032
Figure 65. Japan Budesonide Sales Value by Dosage Form (%), 2025 vs 2032
Figure 66. Japan Budesonide Sales Value by Application (%), 2025 vs 2032
Figure 67. South Korea Budesonide Sales Value (US$ Million), 2021–2032
Figure 68. South Korea Budesonide Sales Value by Dosage Form (%), 2025 vs 2032
Figure 69. South Korea Budesonide Sales Value by Application (%), 2025 vs 2032
Figure 70. Southeast Asia Budesonide Sales Value (US$ Million), 2021–2032
Figure 71. Southeast Asia Budesonide Sales Value by Dosage Form (%), 2025 vs 2032
Figure 72. Southeast Asia Budesonide Sales Value by Application (%), 2025 vs 2032
Figure 73. India Budesonide Sales Value (US$ Million), 2021–2032
Figure 74. India Budesonide Sales Value by Dosage Form (%), 2025 vs 2032
Figure 75. India Budesonide Sales Value by Application (%), 2025 vs 2032
Figure 76. Budesonide Industrial Chain
Figure 77. Budesonide Manufacturing Cost Structure
Figure 78. Channels of Distribution (Direct Sales, and Distribution)
Figure 79. Bottom-up and Top-down Approaches for This Report
Figure 80. Data Triangulation
Figure 81. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Budesonide in 2026?
The global market size of Budesonide in 2026 was 9309 Million USD.
Which companies rank high in the global Budesonide market?
What was the global market size of Budesonide in 2032?
What is the annual compound growth rate of the global Budesonide market size from 2026 to 2032?
Which region is expected to have the highest market share?
Related Reports
Global Budesonide Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Budesonide market is projected to grow from US$ 8994 million in 2025 to US$ 11245 million by 2032, at a CAGR of 3.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-07-08
Pages: 205
USD 4900.00
(Single User License)
Global Budesonide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Budesonide market size was US$ 8994 million in 2025 and is forecast to reach a readjusted size of US$ 11245 million by 2032 with a CAGR of 3.2% during the forecast period 2026-2032.
Published Date: 2026-07-08
Pages: 170
USD 4250.00
(Single User License)
Global Budesonide Market Research Report 2026
The global Budesonide market was valued at US$ 8994 million in 2025 and is anticipated to reach US$ 11245 million by 2032, at a CAGR of 3.2% from 2026 to 2032.
Published Date: 2026-07-08
Pages: 155
USD 2900.00
(Single User License)
Global Budesonide Market Report, History and Forecast 2021-2032
The global market for Budesonide was valued at US$ 8984 million in the year 2023 and is projected to reach a revised size of US$ 11165 million by 2030, growing at a CAGR of 3.2% during the forecast period 2024-2030.
Published Date: 2026-06-17
Pages: 133
USD 3350.00
(Single User License)
Global Budesonide Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Budesonide market is projected to grow from US$ 8732 million in 2024 to US$ 10850 million by 2031, at a CAGR of 3.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 153
USD 4900.00
(Single User License)
Global Budesonide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Budesonide was estimated to be worth US$ 8732 million and is forecast to reach approximately US$ 10850 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 144
USD 5900.00
(Single User License)
Global Budesonide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Budesonide market size was US$ 8732 million in 2024 and is forecast to a readjusted size of US$ 10850 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 99
USD 4250.00
(Single User License)
Budesonide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Budesonide was estimated to be worth US$ 8732 million in 2024 and is forecast to a readjusted size of US$ 10850 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 126
USD 3950.00
(Single User License)
Global Budesonide Market Research Report 2025
The global market for Budesonide was valued at US$ 8732 million in the year 2024 and is projected to reach a revised size of US$ 10850 million by 2031, growing at a CAGR of 3.2% during the forecast period.
Published Date: 2025-01-16
Pages: 91
USD 2900.00
(Single User License)
Global Budesonide Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
Published Date: 2024-04-17
Pages: 156
USD 5600.00
(Single User License)
Global Budesonide Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Budesonide market is projected to grow from US$ 8994 million in 2025 to US$ 11245 million by 2032, at a CAGR of 3.2% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-07-08
Pages: 205
USD 4900.00 (Single User License)Global Budesonide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Budesonide market size was US$ 8994 million in 2025 and is forecast to reach a readjusted size of US$ 11245 million by 2032 with a CAGR of 3.2% during the forecast period 2026-2032.
Published: 2026-07-08
Pages: 170
USD 4250.00 (Single User License)Global Budesonide Market Research Report 2026
The global Budesonide market was valued at US$ 8994 million in 2025 and is anticipated to reach US$ 11245 million by 2032, at a CAGR of 3.2% from 2026 to 2032.
Published: 2026-07-08
Pages: 155
USD 2900.00 (Single User License)Global Budesonide Market Report, History and Forecast 2021-2032
The global market for Budesonide was valued at US$ 8984 million in the year 2023 and is projected to reach a revised size of US$ 11165 million by 2030, growing at a CAGR of 3.2% during the forecast period 2024-2030.
Published: 2026-06-17
Pages: 133
USD 3350.00 (Single User License)Global Budesonide Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Budesonide market is projected to grow from US$ 8732 million in 2024 to US$ 10850 million by 2031, at a CAGR of 3.2% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 153
USD 4900.00 (Single User License)Global Budesonide Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Budesonide was estimated to be worth US$ 8732 million and is forecast to reach approximately US$ 10850 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 144
USD 5900.00 (Single User License)Global Budesonide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Budesonide market size was US$ 8732 million in 2024 and is forecast to a readjusted size of US$ 10850 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 99
USD 4250.00 (Single User License)Budesonide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Budesonide was estimated to be worth US$ 8732 million in 2024 and is forecast to a readjusted size of US$ 10850 million by 2031 with a CAGR of 3.2% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 126
USD 3950.00 (Single User License)Global Budesonide Market Research Report 2025
The global market for Budesonide was valued at US$ 8732 million in the year 2024 and is projected to reach a revised size of US$ 10850 million by 2031, growing at a CAGR of 3.2% during the forecast period.
Published: 2025-01-16
Pages: 91
USD 2900.00 (Single User License)Global Budesonide Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
Published: 2024-04-17
Pages: 156
USD 5600.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now